CRS
Overvalued by 87.4% based on the discounted cash flow analysis.
Market cap | $6.69 Billion |
---|---|
Enterprise Value | $7.18 Billion |
Dividend Yield | $0.7966 (0.59%) |
Earnings per Share | $2.62 |
Beta | 1.15 |
Outstanding Shares | 49,608,268 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 51.03 |
---|---|
PEG | 35.5 |
Price to Sales | 2.46 |
Price to Book Ratio | 4.23 |
Enterprise Value to Revenue | 2.6 |
Enterprise Value to EBIT | 20.34 |
Enterprise Value to Net Income | 38 |
Total Debt to Enterprise | 0.1 |
Debt to Equity | 0.43 |
No data
No data